Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (13)

2016

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Arginase activity and CD3ζ expression after major surgery

    Intensive Care Medicine

  2. ERK1/2 acts as a switch between necrotic and apoptotic cell death in ether phospholipid edelfosine-treated glioblastoma cells

    Pharmacological Research, Vol. 95-96, pp. 2-11

  3. Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosine

    Oncotarget, Vol. 6, Núm. 16, pp. 14596-14613

  4. Inhibition of granulomatous inflammation and prophylactic treatment of schistosomiasis with a combination of edelfosine and Praziquantel

    PLoS Neglected Tropical Diseases, Vol. 9, Núm. 7

  5. Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling

    Apoptosis, Vol. 20, Núm. 5, pp. 584-606

  6. Lipid rafts as major platforms for signaling regulation in cancer

    Advances in Biological Regulation, Vol. 57, pp. 130-146

  7. Triggers and signaling cross-talk controlling cell death commitment

    Cell Cycle

2014

  1. Arginase as a new concern in blood transfusion

    Blood Transfusion

  2. Necroptosis is associated with low procaspase-8 and active RIPK1 and -3 in human glioma cells

    Oncoscience, Vol. 1, Núm. 10, pp. 649-664

2012

  1. Relación entre la actividad arginasa y el tiempo de conservación de los concentrados de hematíes

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 59, Núm. 6, pp. 315-320

2009

  1. Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis

    Journal of Pharmacology and Experimental Therapeutics, Vol. 329, Núm. 2, pp. 439-449

2008

  1. Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo

    Cancer Research, Vol. 68, Núm. 13, pp. 5216-5225